BioNTech SE has already presented new clinical data from its broad lung cancer pipeline at the 2026 IASLC World Conference on ...

Immunotherapy has transformed cancer treatment, yet many tumors remain stubbornly resistant to its effects. Among the most challenging are "cold tumors," including ovarian, breast, and prostate ...

Among 135 patients receiving first-line nivolumab/ipilimumab, 57 received second-line therapy, and 41 received ...

The Bravo star is undergoing regular treatment for cancer after melanoma metastasized to her brain and lungs last year ...

Immunotherapy that targets tumor-associated macrophages, a type of immune cell in the tumor microenvironment, works only if ...

A new study led by researchers at The University of Texas MD Anderson Cancer Center has shown that inflammatory arthritis ...

Results from a groundbreaking clinical trial could soon change the way certain types of cancers are treated. A study published Sunday in the New England Journal of Medicine found that immunotherapy ...

A joint research team—led by professor Young Seok Cho from the School of Medicine, alongside professor James J. Moon from the University of Michigan—has developed the world's first oral, ...

The Parker Institute for Cancer Immunotherapy (PICI) today announced its 2026 class of Early Career Researcher awardees. The five investigators selected this year will receive more than $1 million in ...

A person receives subcutaneous immunotherapy as an injection under the skin. This treatment method has shown similar effectiveness to intravenous (IV) infusions that healthcare professionals often use ...

But simpler, cheaper options will continue to fill the need for many practices ...